Furthermore, IF for p-EGFR expression was performed on these tumor masses, and in accordance with the IHC results, a recovery in p-EGFR activation was observed upon the co-administration of Gefitinib with OA (Additional file 4: Figure S3). Here, EGFR is linked to neoplasm.